Klinefelter syndrome;Klinefelter-Syndrom

Deutsches Arzteblatt International

Volumn 110, Issue 20, 2013, Pages 347-353

  Nieschlag, Eberhard ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ADOLESCENT DISEASE; ANDROGEN THERAPY; ANEUPLOIDY; ARTICLE; AZOOSPERMIA; BODY HEIGHT; EPILEPSY; ERECTILE DYSFUNCTION; GYNECOMASTIA; HUMAN; HYPOGONADISM; KLINEFELTER SYNDROME; LIBIDO; MEDICAL LITERATURE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; QUALITY OF LIFE; SEX CHROMOSOME ABERRATION; SOCIALIZATION; TESTIS BIOPSY; THROMBOSIS; VARICOSIS; VERBALIZATION;

EID: 84906329056     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0347     Document Type: Article

References (40)

1. Klinefelter H.F., Reifenstein EC, Albright F: Syndrome characterized by gy-necomastia, aspermatogenesis without A-Leydigism, and increased excretion of follicle-stimulating hormone. J Clin Endocrinol 1942; II: 615-27.
2. Lanfranco F, Kamischke A, Zitzmann M., Nieschlag E: Klinefelter's syndrome. Lancet 2004; 364: 273-83.
3. rd edition Heidelberg, Springer: 2009; 199-244.
4. Swerdlow AJ, Higgins CD, Schoemaker M.J., Wright A F, Jacobs PA: Mortality in patients with Klinefelter syndrome in Britain: a cohort study. J Clin Endocrinol Metab 2005; 90: 6516-22.
5. Bojesen A, Juul S, Birkebaek N.H., Gravholt CH: Morbidity in Klinefelter syndrome: a Danish register study based on hospital discharge diagnoses. J Clin Endocrinol Metab 2006; 91: 1254-60.
6. Bojesen A, Stochholm K, Juul S., Gravholt CH: Socioeconomic trajectories affect mortality in Klinefelter syndrome. J Clin Endocrinol Metab 2011; 96: 2098-104.
7. Bade K: Das Klinefelter-Syndrom: Berücksichtigung in der ärztlichen Praxis und Literatur. Inauguraldissertation, Medizinische Fakultät der Universität Münster, 2006.
8. Groth KA, Skakkebaek A, Host C., Gravholt CH, Bojesen A: Klinefelter-Syndrome-A clinical update. J Clin Endocrinol Metab 2013; 98: 20-30.
9. Kamischke A, Baumgardt A, Horst J., Nieschlag E: Clinical and diagnostic features of patients with suspected Klinefelter syndrome. J Androl 2003; 24: 41-8.
10. Tüttelmann F., Gromoll J: Novel genetic aspects of Klinefelter's syndrome. Mol Hum Reprod 2010; 16: 386-95.
11. Maiburg M, Repping S, Giltay J: The genetic origin of Klinefelter syndrome and its effect on spermatogenesis. 2012; 98: 253-60.
12. Wikström A.M., Hoei-Hansen CE, Dunkel L., Rajpert-De Meyts E: Immu-noexpression of androgen receptor and nine markers of maturation in the testes of adolescent boys with Klinefelter syndrome: evidence for degeneration of germ cells at the onset of meiosis. J Clin Endocrinol Metab 2007; 92: 714-9.
13. Zitzmann M, Depenbusch M, Gromoll J., Nieschlag E: X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. J Clin Endocrinol Metab 2004: 89: 6208-17.
14. Gravholt CH, Jensen AS, Høst C, Bojesen A: Body composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome. Acta Paediatr 2011; 100: 871-7.
15. Nieschlag E, Nieschlag S, Behre HM: Lifespan and testosterone. Nature 1993; 366: 215.
16. Foresta C, Caretta N, Palego P., et al.: Reduced artery diameters in Klinefelter syndrome. Int J Androl 2012; 35: 720-5.
17. Corona G, Petrone L, Paggi F., et al.: Sexual dysfunction in subjects with Klinefelter's syndrome. Int J Androl 2010; 33: 574-80.
18. Bojesen A, Birkebæk N, Kristensen K., et al.: Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Os-teoporos Int 2011; 22: 1441-50.
19. Ratcliffe S: Long-term outcome in children of sex chromosome abnormalities. Arch Dis Child 1999; 80: 192-95.
20. Ross JL, Roeltgen D P, Stefanatos G, et al: Cognitive and motor development during childhood in boys with Klinefelter syndrome. Am J Med Genet A 2008; 146A: 708-19.
21. Verri A, Cremante A, Clerici F., Destefani V, Radicioni A: Klinefelter's syndrome and psychoneurologic function. Mol Hum Reprod 2010; 16: 425-33.
22. Lewejohann L, Damm OS, Luetjens C.M., et al.: Impaired recognition memory in male mice with a supernumerary X chromosome. Physiol Behav 2009; 96: 23-9.
23. th edition, Deutsche Übersetzung von Nieschlag E, Schlatt S, Behre HM, et al.: Heidelberg: Springer 2012.
24. Shores MM, Smith NL, Forsberg C.W., Anawalt BD, Matsumoto AM: Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 2012; 97: 2050-8.
25. th edition Cambridge: Cambridge University Press, 2012; 408-20.
26. th edition Cambridge: Cambridge University Press 2012; 309-35.
27. Zitzmann M, Nieschlag E: Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men. J Clin Endocrinol Metab 2007; 92: 3844-53.
28. Kühnert B., Byrne M, Simoni M., et al.: Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial. Eur J Endocrinol 2005; 153: 317-26.
29. Behre HM, Tammela TL, Arver S, et al: A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. Aging Male 2012; 15: 198-207.
30. Zitzmann M, Faber S, Nieschlag E: Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006; 91: 4335-43.
31. Bhasin S, Pencina M, Jasuja G.K., et al.: Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab 2011; 96: 2430-9.
32. Kelleher S, Conway AJ, Handelsman DJ: Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab 2004; 89: 3813-7.
33. nd edition, Heidelberg: Springer 2009; 445-64.
34. Wang C, Nieschlag E, Swerdloff R., et al.: Untersuchung, Behandlung und Überwachung des Altershypogonadismus (Late-onset hypogona-dism) des Mannes: ISA, ISSAM, EAU, EAA und ASA Empfehlungen. J Repromed Endokrinol 2009; 7: 60-6.
35. Simm PJ, Zacharin MR: The psychosocial impact of Klinefelter syndromea 10 year review. J Ped Endrocrinol Metab 2006; 19: 499-505.
36. Rogol AD, Tartaglia N: Considerations for androgen therapy in children and adolescents with Klinefelter syndrome (47, XXY). Pediatr Endocrinol Rev 2010; 8 (Suppl 1): 145-50.
37. Braunisch S: Deliktprävention durch ambulante kriminal therapeutische Behandlung des Forensik-Ambulatoriums des Forensisch-Psychiatrischen Dienstes der Universität Bern. Schweizerische Zeitschrift für Kriminologie 2011; 2: 4-8.
38. Mehta A, Paduch DA: Klinefelter syndrome: an argument for early aggressive hormonal and fertility management. Fertil Steril 2012; 98: 274-83.
39. Van Saen D., Gies I, De Schepper J, Tournaye H, Goossens E: Can pubertal boys with Klinefelter syndrome benefit from spermatogonial stem cell banking? Hum Reprod 2012; 27: 323-30.
40. Kliesch S, Zitzmann M, Behre HM: Fertilität beim Klinefelter-Syndrom (47, XXY). Urologe A 2011; 50: 26-32.